Journal des antiviraux et des antirétroviraux

Journal des antiviraux et des antirétroviraux
Libre accès

ISSN: 1948-5964

Volume 6, Problème 3 (2014)

article de recherche

The Prediction of Integrase Inhibitors Efficacy in Third Line Regimen after First and Second Line Antiretroviral Therapy Failure in Senegal

Edmond Tchiakpe, Abou Abdallah Malick Diouara, Moussa Thiam,

Partagez cet article

article de recherche

Recombinant Coree1e2 Protein Expressed in Pichia pastoris Yeast a Candidate Vaccine for Hepatitis C Virus

Mehdi Fazlalipour, Hossein Keyvani, Seyed Hamid Reza Monavari and

Partagez cet article

Article de révision

Reactivation of Hepatitis B Virus Infection Associated with Anti-Tumor Necrosis Factor-α Therapy

Lorenzo Nobili, Lisa Albani, Armando Gabrielli and Gianluca Moroncini

Partagez cet article

article de recherche

Preclinical and Clinical Profile of HIV-1 Integrase Strand-transfer Inhibitor GS-9224 Compared to its Parent Compound GS-9160

Gregg S Jones, Rebecca Hluhanich, Lani M Wieman, Jim Zheng, Wayne Huan

Partagez cet article

Article de révision

New Antiretroviral Therapies and Potential Drug Interactions in HIVInfected Drug Abusers

PSS Rao, TJ Cory and S Kumar

Partagez cet article

article de recherche

Birth Outcomes in HIV-1-Infected Women Receiving Highly Active Antiretroviral Therapy (HAART) Prior to Conception versus During Pregnancy in Yaounde, Cameroon

Anne Esther Njom Nlend, Cecile Zeudja, Suzie Moyo, Annie Nga Motaze and The Therapeutic Committee of Centre Hospitalier d’ESSOS Djoungolo

Partagez cet article

article de recherche

Antiviral Activity of Sirna UL42 against Herpes Simplex Virus Type 1 in HeLa Cell Culture

Hamid Reza Mollaei, Seyed Hamidreza Monavari, Seyedalimohammad Arabzadeh, Mahmood Shams Shahrabadi and Mehdi Fazlalipour

Partagez cet article

article de recherche

Antiretroviral Toxicity Leading to a Medication Change in Multiple HIV Clinics in Resource Limited Settings

Thomas Macharia, Anthony Amoroso, Martine Etienne-Mesubi and Anthony Edozien

Partagez cet article
Top